HTA Conference 2022 - Apr 29 | RingCentral Events
Michalis LIONTOS | Medical Oncologist, Locum Consultant | MD, PhD | National and Kapodistrian University of Athens, Athens | uoa | Division of Clinical Therapeutics, Oncology Department | Research profile
Diabetes mellitus and multiple myeloma; common features of two distinct entities - Tentolouris - 2022 - Diabetes/Metabolism Research and Reviews - Wiley Online Library
Cancers | Free Full-Text | Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study “REBUILD”
HTA Conference 2022 - Apr 29 | RingCentral Events
Maria Alexandra Papadimitriou on LinkedIn: Epi‐miRNAs: Modern mediators of methylation status in human cancers
Metastatic Colorectal Cancer: From Laboratory to Clinical Studies
Charalampos Filippatos - Private - Medical Corps - Hellenic Army | LinkedIn
Dr. Diamantis Tsilimigras, MD – Columbus, OH | General Surgery
IJMS | Free Full-Text | Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma
HTA Conference 2022 - Apr 29 | RingCentral Events
Maria Alexandra Papadimitriou on LinkedIn: Epi‐miRNAs: Modern mediators of methylation status in human cancers
Amir Ali RAHNEMAI AZAR | Fellow | University of Wisconsin–Madison, Wisconsin | UW | Surgical Oncology | Research profile
Efficacy and Toxicity of Selinexor: Importance of Dose Intensity and Post Progression Outcomes - YouTube
CREClinicalTrials/clinicaltrials.fasta at master · abannachbrown/CREClinicalTrials · GitHub
HTA Conference 2022 - Apr 29 | RingCentral Events
ioannis politis - University Professor - Agricultural University of Athens | LinkedIn
Ioanna Kanteli - National & Kapodistrian University of Athens - Víron, Attiki, Greece | LinkedIn
Efficacy and Toxicity of Selinexor: Importance of Dose Intensity and Post Progression Outcomes - YouTube
John FUNG | Chief Section of Transplant Surgery | MD, PhD | The University of Chicago Medical Center, Chicago | Department of Surgery | Research profile - Page 2
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group - The Lancet Oncology
Stefan BUETTNER | MD PhD | Erasmus University Rotterdam, Rotterdam | EUR | Department of Surgery | Research profile
